Cover Image
Market Research Report

Global Brain Monitoring Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022

Published by Occams Business Research & Consulting Pvt. Ltd. Product code 346112
Published Content info 140 Pages
Delivery time: Inquiry
Price
Back to Top
Global Brain Monitoring Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022
Published: March 29, 2016 Content info: 140 Pages
Description

Global brain monitoring device market provides quality treatment to patients suffering from brain and related diseases such as brain tumor, epilepsy, sleep disorder and so on. The technological advancement and innovations in medical device and treatment enable to provide quality brain monitoring services to patients.

In the present scenario the research and development in global brain monitoring device market has paced up due to support from government and private players. Additionally, FDA approvals are giving rise to significant scope in global brain monitoring device market. Moreover, Technological advancement in the Global brain monitoring device market enables to expand the market and as a result new players are entering the market. Innovations are giving rise to growth of Global brain monitoring device market. Presently the global brain monitoring device market is undergoing rapid expansion with the advancement in surgeries and high awareness in the developed nations such as US and UK. The key driving forces for the global brain monitoring device market are: FDA approvals giving rise to significant scope in global brain monitoring market. Funding from government and private players has also strengthened the global brain monitoring market. Increase in government spending/ private investment in healthcare budgets and R&D respectively, rising case of lifestyle related diseases and so on. Various factors such as High cost of global brain monitoring devices and surgeries are concern for the growth of global brain monitoring market.

The key players in global Astro-Med Inc, Cadwell laboratories Inc, CAS medical systems, Inc, Compumedics limited, Contec medical systems co. ltd, Cortech solutions Inc, Covidien plc, Depuy synthes companies, Elcat GMBH, Elekta AB, Integral lifesciences holdings corporation, MEG international service ltd, Natus medical, Inc, Nihon kohden corporation, Nonin medical, inc, Rimed Ltd, Yokogawa electric corporation, emotive and so on.

Companies Profiled

  • 1. Advanced brain monitoring, Inc
  • 2. Astro-Med Inc
  • 3. Atys medical
  • 4. Cadwell laboratories Inc
  • 5. CAS medical systems, Inc
  • 6. Compumedics limited
  • 7. Contec medical systems co ltd
  • 8. Cortech solutions, Inc
  • 9. Covidien, Plc
  • 10. Depuy synthes companies
  • 11. Elcat GMBH
  • 12. Elekta AB
  • 13. Integral lifesciences holdings corporation
  • 14. MEG international service ltd
  • 15. Natus medical, Inc
  • 16. Nihon kohden corporation
  • 17. Nonin medical, inc
  • 18. Rimed Ltd
  • 19. Yokogawa electric corporation
  • 20. Emotive
  • 21. Autonomic technologies
  • 22. Neurospace Inc
  • 23. Trans enterix
  • 24. Neurovigil
  • 25. M-brain
  • 26. GE healthcare
  • 27. Philips
  • 28. Siemens
  • 29. Ornim medical
  • 30. Third eye diagnostic

This Occams Research Report covers

  • 1. Historical data
  • 2. Revenue forecasts, growth rates and CAGR upto 2022
  • 3. Industry Analysis
  • 4. Competitive Analysis
  • 5. Key geographic growth data
  • 6. In-depth profiling of companies
Table of Contents
Product Code: HME-1501015

Table of Contents

1. Introduction

  • 1.1. Executive summary
  • 1.2. Estimation methodology

2. Market overview

  • 2.1. Market definition and scope
  • 2.2. Key findings
  • 2.3. Parametric analysis
    • 2.3.1. Prevalence & incidence rate of brain disorders
    • 2.3.2. Prevalence & incidence rate of neuro-degenerative diseases
    • 2.3.3. Hospital and research center across geographies
    • 2.3.4. Rise in disposable incomes in emerging economies
    • 2.3.5. Healthcare expenditure across geographies
  • 2.4. Key market insights
    • 2.4.1. Top 3 emerging countries
    • 2.4.2. Top 3 revenue generating segments
    • 2.4.3. Top growing markets and emerging trends
    • 2.4.4. Patent analysis
      • 2.4.4.1. WO/2001/057275A2: Patents for human genome derived single exon nucleic acid probes useful for analysis of gene expression in human brain.
      • 2.4.4.2. US20110282230: neuro-diagnostic monitoring and display system
      • 2.4.4.3. 7801618: Auto adjusting system for brain tissue stimulator
      • 2.4.4.4. US20080319511: Auto adjusting system for brain tissue stimulator
    • 2.4.5. R&D scenario in brain monitoring market
      • 2.4.5.1. R&d in development of premature and infant babies
      • 2.4.5.2. R&d in advance brain monitoring devices
      • 2.4.5.3. Clinical trials for Parkinson's disease for brain behavioral research
      • 2.4.5.4. Clinical trials for Alzheimer's disease for brain behavioral research
  • 2.5. Competitive intelligence
    • 2.5.1. Market share analysis
    • 2.5.2. Top winning strategies
    • 2.5.3. Case studies: top competitive moves
  • 2.6. Value chain analysis
  • 2.7. Key buying criteria
  • 2.8. Strategic recommendation
  • 2.9. Strategic conclusions

3. Market determinants

  • 3.1. Market drivers
    • 3.1.1. FDA approvals giving rise to significant scope in global brain monitoring market
    • 3.1.2. Funding from government and private players to boost global brain monitoring market
    • 3.1.3. Rise in neurodegenerative diseases
    • 3.1.4. Rise in psychiatric diseases and brain disorders
    • 3.1.5. Rise in adoption of minimally invasive surgeries driving the brain monitoring market
    • 3.1.6. Technological advancement enables to expand global brain monitoring market
    • 3.1.7. Innovation giving rise to growth of global brain monitoring market
    • 3.1.8. Global increase in healthcare expenditure
    • 3.1.9. Rise in adoption of EEG and other wearable devices for brain
  • 3.2. Market restraints
    • 3.2.1. High cost of brain monitoring devices and treatment
    • 3.2.2. Reimbursement issues affecting the global brain monitoring market
  • 3.3. Market challenges
    • 3.3.1. Creating awareness for global brain monitoring devices
    • 3.3.2. Less trained professionals to deal with brain monitoring devices and treatment
    • 3.3.3. Global economic slowdown may affect the global brain monitoring market
    • 3.3.4. Stringent government regulations and policies
  • 3.4. Market opportunities
    • 3.4.1. Rise in clinical trials for neuro-cognitive diseases
    • 3.4.2. Advance brain monitoring devices available in the market

4. Sector Analysis

  • 4.1. Parent market
  • 4.2. Sub-segment market
  • 4.3. Alternative market

5. Market Segmentation

  • 5.1. Global brain monitoring market
    • 5.1.1. Global brain monitoring market by product, 2014-2021,($ millions)
      • 5.1.1.1. Global electroencephalograph market, 2014-2021,($ millions)
      • 5.1.1.2. Global transcranial doppler market, 2014-2021,($ millions)
      • 5.1.1.3. Global magnetoencephalograph market, 2014-2021,($ millions)
      • 5.1.1.4. Global intracranial pressure monitor market, 2014-2021,($ millions)
      • 5.1.1.5. Global cerebral oximeter market, 2014-2021,($ millions)
      • 5.1.1.6. Global accessories market, 2014-2021,($ millions)
      • 5.1.1.7. Global other market , 2014-2021,($ millions)
    • 5.1.2. Global brain monitoring market by application, 2014-2021,($ millions)
      • 5.1.2.1. Global electroencephalograph market , 2014-2021,($ millions)
        • 5.1.2.1.1. Global epilepsy market, 2014-2021,($ millions)
        • 5.1.2.1.2. Global sleep disorder market, 2014-2021,($ millions)
        • 5.1.2.1.3. Global coma and brain death market, 2014-2021,($ millions)
        • 5.1.2.1.4. Global brain tumor market, 2014-2021,($ millions)
        • 5.1.2.1.5. Global others market, 2014-2021,($ millions)
      • 5.1.2.2. Global transcrannial doppler market, 2014-2021,($ millions)
        • 5.1.2.2.1. Global intracrannial stenosis market, 2014-2021,($ millions)
        • 5.1.2.2.2. Global subarachnoid hemorrhage market, 2014-2021,($ millions)
        • 5.1.2.2.3. Global emboli detection market, 2014-2021,($ millions)
        • 5.1.2.2.4. Global sickle cell disease market, 2014-2021,($ millions)
        • 5.1.2.2.5. Global other market, 2014-2021,($ millions)
      • 5.1.2.3. Global magnetoencephalography market, 2014-2021,($ millions)
        • 5.1.2.3.1. Global brain research studies market, 2014-2021,($ millions)
        • 5.1.2.3.2. Global autistic disorders market, 2014-2021,($ millions)
        • 5.1.2.3.3. Global others market, 2014-2021,($ millions)
      • 5.1.2.4. Global intracranial pressure monitors market, 2014-2021,($ millions)
        • 5.1.2.4.1. Global traumatic brain injury market, 2014-2021,($ millions)
        • 5.1.2.4.2. Global intracerebral hemorrhage market, 2014-2021,($ millions)
        • 5.1.2.4.3. Global meningitis market, 2014-2021,($ millions)
        • 5.1.2.4.4. Global others market, 2014-2021,($ millions)
      • 5.1.2.5. Global cerebral oximeters market, 2014-2021,($ millions)
        • 5.1.2.5.1. Global cardiac/vascular surgery market, 2014-2021,($ millions)
        • 5.1.2.5.2. Global shoulder surgery market, 2014-2021,($ millions)
        • 5.1.2.5.3. Global single lung ventilation market, 2014-2021,($ millions)
        • 5.1.2.5.4. Global others market, 2014-2021,($ millions)
  • 5.2. Global Brain monitoring market by end user, 2014-2021,($ millions)
    • 5.2.1. Hospitals
    • 5.2.2. clinics
    • 5.2.3. research centers
    • 5.2.4. others

6. Competitive Landscape

  • 6.1. Market share
  • 6.2. Strategy - An analysis across tiers

7. Geographical analysis

  • 7.1. North America brain monitoring market, 2014-2021,($millions)
    • 7.1.1. United States (U.S.) brain monitoring market, 2014-2021,($millions)
    • 7.1.2. Canada brain monitoring market, 2014-2021,($millions)
  • 7.2. Europe brain monitoring market, 2014-2021,($millions)
    • 7.2.1. United Kingdom (UK) brain monitoring market, 2014-2021,($millions)
    • 7.2.2. France brain monitoring market, 2014-2021,($millions)
    • 7.2.3. Germany brain monitoring market, 2014-2021,($millions)
    • 7.2.4. Spain brain monitoring market, 2014-2021,($millions)
    • 7.2.5. Italy brain monitoring market, 2014-2021,($millions)
    • 7.2.6. RoE brain monitoring market, 2014-2021,($millions)
  • 7.3. Asia Pacific brain monitoring market, 2014-2021,($millions)
    • 7.3.1. India brain monitoring market, 2014-2021,($millions)
    • 7.3.2. China brain monitoring market, 2014-2021,($millions)
    • 7.3.3. Japan brain monitoring market, 2014-2021,($millions)
    • 7.3.4. Korea brain monitoring market, 2014-2021,($millions)
    • 7.3.5. Australia brain monitoring market, 2014-2021,($millions)
    • 7.3.6. RoAPAC brain monitoring market, 2014-2021,($millions)
  • 7.4. Rest of the world market, 2014-2021,($millions)
    • 7.4.1. Latin America brain monitoring market, 2014-2021,($millions)
    • 7.4.2. MENA brain monitoring market, 2014-2021,($millions)
    • 7.4.3. Africa brain monitoring market, 2014-2021,($millions)

8. Company Profiling: - (Over, SCOT analysis, strategic review)

  • 8.1. Advanced brain monitoring, Inc
  • 8.2. Astro-Med Inc
  • 8.3. Atys medical
  • 8.4. Cadwell laboratories Inc
  • 8.5. CAS medical systems, Inc
  • 8.6. Compumedics limited
  • 8.7. Contec medical systems co. ltd
  • 8.8. Cortech solutions, Inc
  • 8.9. Covidien, Plc
  • 8.10. Depuy synthes companies
  • 8.11. Elcat GMBH
  • 8.12. Elekta AB
  • 8.13. Integral lifesciences holdings corporation
  • 8.14. MEG international service ltd
  • 8.15. Natus medical, Inc
  • 8.16. Nihon kohden corporation
  • 8.17. Nonin medical, inc
  • 8.18. Rimed Ltd
  • 8.19. Yokogawa electric corporation
  • 8.20. Emotive
  • 8.21. Autonomic technologies
  • 8.22. Neurospace Inc
  • 8.23. Trans enterix
  • 8.24. Neurovigil
  • 8.25. M-brain
  • 8.26. GE healthcare
  • 8.27. Philips
  • 8.28. Siemens
  • 8.29. Ornim medical
  • 8.30. Third eye diagnostic
Back to Top